The American Diabetes Association (ADA) and the European Association for the Study of
Diabetes (EASD) convened a writing group to develop a consensus statement on the …

Monogenic diabetes includes several clinical conditions generally characterized by early-
onset diabetes, such as neonatal diabetes, maturity-onset diabetes of the young (MODY) …

The convergence of advances in medical science, human biology, data science, and
technology has enabled the generation of new insights into the phenotype known as …

Monogenic diabetes refers to diabetes mellitus (DM) caused by a mutation in a single gene
and accounts for approximately 1%–5% of diabetes. Correct diagnosis is clinically critical for …

C-peptide is a widely used measure of pancreatic beta cell function. It is produced in
equimolar amounts to endogenous insulin but is excreted at a more constant rate over a …

Maturity-onset diabetes of the young (MODY) is characterized by autosomal dominant
inheritance, onset before 25 years of age, absence of β-cell autoimmunity, and sustained …

Advances in molecular methods and the ability to share large population-based datasets are
uncovering heterogeneity within diabetes types, and some commonalities between types …

The precision medicine approach of tailoring treatment to the individual characteristics of
each patient or subgroup has been a great success in monogenic diabetes subtypes, MODY …

Maturity-onset diabetes of the young, or MODY-monogenic diabetes, is a not-so-rare
collection of inherited disorders of non-autoimmune diabetes mellitus that remains …

OBJECTIVE With rising obesity, it is becoming increasingly difficult to distinguish between
type 1 diabetes (T1D) and type 2 diabetes (T2D) in young adults. There has been …